Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iTREMT: Tirofiban for Perfusion Improvement Post-Thrombectomy
NCT04818944Phase 2Withdrawn
- Sponsor
- University of Iowa
- Start
- Mar 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tirofiban in ischemic stroke, sponsored by University of Iowa. Planned start Mar 2023; status: withdrawn.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04818944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04818944.